Prevention of acute and recurrent otitis media.
Pelton
S
S
Division of Pediatric Infectious Diseases, Boston Medical Center, MA 02118, USA.
D000208:Acute Disease; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001422:Bacterial Adhesion / Q000187:drug effects; D006193:Haemophilus influenzae / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D007223:Infant; D009844:Oligosaccharides / Q000627:therapeutic use*; D010033:Otitis Media / Q000382:microbiology / Q000517:prevention & control*; D022242:Pneumococcal Vaccines / Q000627:therapeutic use*; D055502:Secondary Prevention; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; C415922:NE 1530; D009844:Oligosaccharides; D022242:Pneumococcal Vaccines